Request Deal Involvement
Gilead Sciences completed the acquisition of Immunomedics for $21bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Wachtell Lipton Rosen & Katz
financial advisors
TD Cowen
financial advisors
Bank of America
financial advisors
Centerview Partners
legal advisors to financial advisors
Sullivan & Cromwell
legal advisors to financial advisors
Goodwin Procter
financial advisors
Lazard
financial advisors
Morgan Stanley
legal advisors
Davis Polk & Wardwell
legal advisors to financial advisors
Cravath Swaine & Moore
pr advisors
Joele Frank
financial advisors
Mizuho Securities
legal advisors to financial advisors
Fried Frank Harris Shriver & Jacobson
or
Principals
target
IMMUNOMEDICS
bidder
GILEAD SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite